A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
With its world-renowned healthcare network and prestigious medical research institutions, Boston is a premier destination for a wide range of clinical trials. Major centers such as Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and the Dana-Farber Cancer Institute lead groundbreaking studies across various medical fields. These institutions are at the forefront of innovation, making Boston a hub for cutting-edge clinical research.
Why choose Boston for clinical trials?
Boston stands out as a leader in healthcare and life science, and has become an important destination for participants taking part in clinical trials. With world-class medical institutions and a diverse patient population, researchers can deliver more reliable and relevant results.
The city is also home to an innovative research ecosystem, strengthened by close collaborations between hospitals, universities, and biotech companies, making it a hub for cutting-edge clinical studies.
Common conditions studied in Boston
Boston is renowned for its extensive clinical research across a wide array of medical conditions, driven by its world-class hospitals and research institutions.
Cancer
Boston's Dana-Farber Cancer Institute, Massachusetts General Hospital Cancer Center, and other top institutions are renowned for conducting cutting-edge cancer research. They lead oncology clinical trials focusing on a wide array of cancers such as breast, lung, colorectal, and melanoma.
These trials explore innovative treatments, including CAR-T cell therapy, immune checkpoint inhibitors, precision oncology, and experimental drugs designed to target specific genetic mutations in tumors.
Cardiovascular disease
Boston is a leader in cardiovascular research, addressing diseases such as coronary artery disease, heart failure, hypertension, and atrial fibrillation. Institutions like the Brigham and Women’s Hospital Heart & Vascular Center and Beth Israel Deaconess Medical Center focus on clinical trials investigating new medications, minimally invasive surgical procedures, and medical devices like left ventricular assist devices (LVADs) and transcatheter aortic valve replacements (TAVR). Studies often explore novel biomarkers for early detection and prevention strategies.
Neurological disorders
Boston's status as a hub for neuroscience research is underscored by its extensive studies into Alzheimer’s disease, Parkinson’s disease, ALS (Lou Gehrig's disease), epilepsy, and multiple sclerosis (MS).
Major hospitals such as Massachusetts General Hospital and Boston Children's Hospital lead clinical trials on disease-modifying therapies, neuroprotective agents, and gene-editing technologies. Researchers also investigate new treatments for stroke recovery and traumatic brain injuries.
Autoimmune diseases
The city’s leading research centers conduct numerous trials targeting autoimmune conditions such as rheumatoid arthritis, lupus, and Crohn's disease. These trials frequently test advanced biologic therapies, monoclonal antibodies, and small molecule drugs designed to dampen the immune response or reset immune system function. Personalized approaches like precision immunotherapy and the use of stem cells are also areas of active exploration in Boston.
Diabetes and endocrine disorders
Boston has long been at the forefront of diabetes research, with a particular focus on innovative treatments for both Type 1 and Type 2 diabetes. Trials often explore new forms of insulin, artificial pancreas technologies, continuous glucose monitors, and regenerative medicine approaches like beta-cell transplantation. Endocrine research also spans conditions such as thyroid disorders, obesity, and metabolic syndrome.
Rare diseases
Boston’s research institutions are committed to tackling rare diseases, with several clinical trials focused on orphan diseases such as cystic fibrosis, Duchenne muscular dystrophy, and other rare genetic conditions. These trials often test gene therapies, CRISPR-based gene editing, and experimental drugs designed to address the underlying causes of these conditions.
Local regulations and guidelines
Clinical trials in Boston adhere to rigorous guidelines and regulations to ensure participant safety, ethical conduct, and scientific integrity. These trials must comply with federal standards set by the FDA and HHS, as well as the Common Rule for human research ethics. Institutions conducting clinical trials must have Institutional Review Boards (IRBs) that review and approve research protocols to ensure they prioritize participant rights and safety. Additionally, the informed consent process ensures that participants fully understand the risks and benefits before enrolling.
Massachusetts also enforces strict state-specific regulations, particularly through the Department of Public Health (DPH) and HIPAA guidelines for patient privacy. Researchers in Boston follow Good Clinical Practice (GCP) standards, and all clinical trials are required to register on ClinicalTrials.gov for transparency.
Benefits of participating in clinical trials
Participating in a clinical trial offers a unique chance to access cutting-edge treatments and therapies before they are widely available. During a clinical trial, participants benefit from expert care provided by top healthcare professionals, ensuring personalized attention and thorough monitoring throughout the study.
Clinical trial participation plays a crucial role in advancing medical research, often leading to groundbreaking discoveries in treatment and prevention. By joining a trial, individuals make a meaningful contribution to the development of new medical knowledge, ultimately improving future healthcare for others.
Worried about the risks of participating in a clinical trial? Read our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
How to enroll in a clinical trial in Boston
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.